China Solid Tumor NPP Lead (Associate Director)
Johnson & Johnson View all jobs
- Beijing
- Permanent
- Full-time
Matrix collaboration with: APSO, OpCo Solid Tumors teams, China R&D (CCT), Medical, Market Access, BD, and Commercial OperationsPurpose of the RoleThe China Solid Tumors Strategic Marketing – New Product Planning Lead is accountable for shaping and driving the long‑term pipeline and portfolio strategy for Solid Tumour oncology in China, from early clinical stages through pre‑launch readiness.This role serves as the strategic “bridge” between global asset development and China’s unique market needs, ensuring future assets, indications, and business models are fit‑for‑China, competitively differentiated, and launch‑ready. The role leads China NPP strategy across key solid tumour disease areas and plays a critical role in influencing global development priorities, lifecycle strategy, and portfolio investment decisions.Key Responsibilities1. China Solid Tumours Pipeline & Portfolio StrategyOwn and drive the China Solid Tumours NPP strategy, spanning early to late‑stage assets and indications.Define China‑specific strategic imperatives, disease area priorities, and portfolio sequencing aligned to unmet medical need and commercial opportunity.Lead pipeline sufficiency and portfolio gap analysis versus current and future competitive landscapes in China.Develop and articulate clear China value narratives for pipeline assets to support governance, prioritization, and investment decisions.2. Early Asset & Indication ShapingInfluence Target Product Profiles (TPPs), indication sequencing, and clinical development strategies to optimize China relevance.Partner closely with China Compound Team (CCT), APSO DAS lead, and Medical Affairs to ensure early integration of commercial insights.Provide strategic input at key global development milestones (pre‑IND, Phase I–III, lifecycle extensions).Identify China‑specific opportunities including biomarkers, precision medicine strategies, combination approaches, and novel access models.3. Pre‑Launch & Launch Excellence ReadinessLead China pre‑launch strategic planning for priority solid tumour assets, ensuring seamless transition from NPP to inline teams.Define future launch archetypes, success metrics, and critical enablers (diagnostics, patient pathways, ecosystem readiness).Ensure early alignment across Commercial, Medical, Market Access, and Operations on launch ambition and execution model.4. Cross‑Functional & Global LeadershipAct as the China strategic interface to global and regional Solid Tumours teams.Lead and influence complex, matrixed cross‑functional teams without direct authority.Partner with Business Development to assess external opportunities, collaborations, and pipeline expansion options relevant to China.Represent China perspectives in global governance forums, ensuring China’s voice is clearly articulated and influential.5. Strategic Planning & GovernanceDrive China Solid Tumours long‑range strategic planning (LRFP, BP) from a pipeline and portfolio perspective.Support senior leadership with high‑quality strategic insights, scenario planning, and decision frameworks.Ensure all activities are compliant with internal governance, ethics, and regulatory requirements.Key StakeholdersAP Solid Tumours DAS & Asset TeamsChina Oncology Leadership TeamChina R&D / CCTMedical Affairs, Market Access, Commercial ExcellenceBusiness Development & Strategic InsightsQualifications & ExperienceRequiredBachelor’s degree required; MBA, PhD, PharmD, or MD strongly preferredExtensive experience in oncology strategic marketing, NPP, portfolio strategy, or commercial strategyStrong understanding of China oncology market dynamics, including policy, access, and competitive environmentProven ability to influence global development and lifecycle strategy without direct reporting linesExperience across early and late‑stage pipeline assetsPreferredSolid tumour therapeutic area expertise (e.g., lung, GU, GI, bladder, CRC, breast, head & neck)Experience working in matrixed global–regional–local organizationsExposure to precision medicine, diagnostics, or novel modalitiesStrong strategic storytelling and executive communication skillsCritical CapabilitiesEnterprise‑level strategic thinkingStrong commercial and clinical acumenHigh influence and stakeholder management capabilityComfort with ambiguity and early‑stage decision‑makingAbility to translate complexity into clear strategic choicesSuccess MeasuresStrength and clarity of China Solid Tumours pipeline strategyDegree of China influence on global asset and indication decisionsQuality of pre‑launch readiness for priority assetsLeadership impact across cross‑functional and global stakeholdersRequired Skills:Preferred Skills: Brand Marketing, Brand Marketing, Brand Positioning Strategy, Business Alignment, Business Storytelling, Business Valuations, Cross-Functional Collaboration, Customer Intelligence, Data Analysis, Data-Driven Decision Making, Developing Others, Digital Strategy, Execution Focus, Financial Analysis, Go-to-Market Strategies, Inclusive Leadership, Industry Analysis, Leadership, Market Research, Negotiation, Problem Solving, Product Development Lifecycle, Product Portfolio Management, Product Strategies, Program Management {+ 2 more}